1-16 of 16
Hua Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study)

Feng Wang, Ming-Ming He, Jian Xiao, Yan-Qiao Zhang, Xiang-Lin Yuan, Wei-Jia Fang, Yan Zhang, Wei Wang, Xiao-Hua Hu, Zhi-Gang Ma, Yi-Chen Yao, Zhi-Xiang Zhuang, Fu-Xiang Zhou, Jie-Er Ying, Ying Yuan, Qing-Feng Zou, Zeng-Qing Guo, Xiang-Yuan Wu, Ying Jin, Zong-Jiong Mai, Zhi-Qiang Wang, Hong Qiu, Ying Guo, Si-Mei Shi, Shuang-Zhen Chen, Hui-Yan Luo, Dong-Sheng Zhang, Feng-Hua Wang, Yu-Hong Li, Rui-Hua Xu
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (19): 4232–4239.
https://doi.org/10.1158/1078-0432.CCR-22-0655
Published: 03 October 2022
View article titled, A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study)
Open the PDF for A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study) in another window
Includes: Supplementary data
Journal Articles

CUB Domain-Containing Protein 1 (CDCP1) Is a Target for Radioligand Therapy in Castration-Resistant Prostate Cancer, including PSMA Null Disease

Ning Zhao, Shalini Chopra, Kai Trepka, Yung-Hua Wang, Sasank Sakhamuri, Nima Hooshdaran, Hyunjung Kim, Jie Zhou, Shion A. Lim, Kevin K. Leung, Emily A. Egusa, Jun Zhu, Li Zhang, Adam Foye, Renuka Sriram, Emily Chan, Youngho Seo, Felix Y. Feng, Eric J. Small, Jonathan Chou, James A. Wells, Rahul Aggarwal, Michael J. Evans
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (14): 3066–3075.
https://doi.org/10.1158/1078-0432.CCR-21-3858
Published: 15 July 2022
View article titled, CUB Domain-Containing Protein 1 (CDCP1) Is a Target for Radioligand Therapy in Castration-Resistant Prostate Cancer, including PSMA Null Disease
Open the PDF for CUB Domain-Containing Protein 1 (CDCP1) Is a Target for Radioligand Therapy in Castration-Resistant Prostate Cancer, including PSMA Null Disease in another window
Includes: Supplementary data
Journal Articles

Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial

Li Chen, Yi-Zhou Jiang, Song-Yang Wu, Jiong Wu, Gen-Hong Di, Guang-Yu Liu, Ke-Da Yu, Lei Fan, Jun-Jie Li, Yi-Feng Hou, Zhen Hu, Can-Ming Chen, Xiao-Yan Huang, A-Yong Cao, Xin Hu, Shen Zhao, Xiao-Yan Ma, Ying Xu, Xiang-Jie Sun, Wen-Jun Chai, Xiaomao Guo, Xizi Chen, Yanhui Xu, Xiao-Yu Zhu, Jian-Jun Zou, Wen-Tao Yang, Zhong-Hua Wang, Zhi-Ming Shao
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (13): 2807–2817.
https://doi.org/10.1158/1078-0432.CCR-21-4313
Published: 01 July 2022
View article titled, Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial
Open the PDF for Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial in another window
Includes: Supplementary data
Journal Articles

Molecular Imaging of Prostate Cancer Targeting CD46 Using ImmunoPET

Sinan Wang, Jun Li, Jun Hua, Yang Su, Denis R. Beckford-Vera, Walter Zhao, Mayuri Jayaraman, Tony L. Huynh, Ning Zhao, Yung-hua Wang, Yangjie Huang, Fujun Qin, Sui Shen, Daniel Gioeli, Robert Dreicer, Renuka Sriram, Emily A. Egusa, Jonathan Chou, Felix Y. Feng, Rahul Aggarwal, Michael J. Evans, Youngho Seo, Bin Liu, Robert R. Flavell, Jiang He
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (5): 1305–1315.
https://doi.org/10.1158/1078-0432.CCR-20-3310
Published: 01 March 2021
View article titled, Molecular Imaging of Prostate Cancer Targeting CD46 Using ImmunoPET
Open the PDF for Molecular Imaging of Prostate Cancer Targeting CD46 Using ImmunoPET in another window
Includes: Supplementary data
Journal Articles

Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic Cancer

Anna Moroz, Yung-Hua Wang, Jeremy M. Sharib, Junnian Wei, Ning Zhao, Yangjie Huang, Zhuo Chen, Alexander J. Martinko, Jie Zhuo, Shion A. Lim, Lydia H. Zhang, Youngho Seo, Sean Carlin, Kevin K. Leung, Eric A. Collisson, Kimberly S. Kirkwood, James A. Wells, Michael J. Evans
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (14): 3608–3615.
https://doi.org/10.1158/1078-0432.CCR-20-0268
Published: 15 July 2020
View article titled, Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic Cancer
Open the PDF for Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic Cancer in another window
Includes: Supplementary data
Journal Articles

Targeting Myddosome Signaling in Waldenström's Macroglobulinemia with the Interleukin-1 Receptor-Associated Kinase 1/4 Inhibitor R191

Haiwen Ni, Fazal Shirazi, Veerabhadran Baladandayuthapani, Heather Lin, Isere Kuiatse, Hua Wang, Richard J. Jones, Zuzana Berkova, Yasumichi Hitoshi, Stephen M. Ansell, Steven P. Treon, Sheeba K. Thomas, Hans C. Lee, Zhiqiang Wang, R. Eric Davis, Robert Z. Orlowski
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (24): 6408–6420.
https://doi.org/10.1158/1078-0432.CCR-17-3265
Published: 13 December 2018
View article titled, Targeting Myddosome Signaling in Waldenström's Macroglobulinemia with the Interleukin-1 Receptor-Associated Kinase 1/4 Inhibitor R191
Open the PDF for Targeting Myddosome Signaling in Waldenström's Macroglobulinemia with the Interleukin-1 Receptor-Associated Kinase 1/4 Inhibitor R191 in another window
Includes: Supplementary data
Journal Articles

CD44+ Cells in Head and Neck Squamous Cell Carcinoma Suppress T-Cell–Mediated Immunity by Selective Constitutive and Inducible Expression of PD-L1

Yunqin Lee, June Ho Shin, Michelle Longmire, Hua Wang, Holbrook E. Kohrt, Howard Y. Chang, John B. Sunwoo
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (14): 3571–3581.
https://doi.org/10.1158/1078-0432.CCR-15-2665
Published: 14 July 2016
View article titled, CD44<sup>+</sup> Cells in Head and Neck Squamous Cell Carcinoma Suppress T-Cell–Mediated Immunity by Selective Constitutive and Inducible Expression of PD-L1
Open the PDF for CD44<sup>+</sup> Cells in Head and Neck Squamous Cell Carcinoma Suppress T-Cell–Mediated Immunity by Selective Constitutive and Inducible Expression of PD-L1 in another window
Includes: Supplementary data
Journal Articles

Obesity, Intrapancreatic Fatty Infiltration, and Pancreatic Cancer

Hua Wang, Anirban Maitra, Huamin Wang
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (15): 3369–3371.
https://doi.org/10.1158/1078-0432.CCR-15-0718
Published: 02 August 2015
View article titled, Obesity, Intrapancreatic Fatty Infiltration, and Pancreatic Cancer
Open the PDF for Obesity, Intrapancreatic Fatty Infiltration, and Pancreatic Cancer in another window
Journal Articles

EGFR Fluorescence In situ Hybridization Pattern of Chromosome 7 Disomy Predicts Resistance to Cetuximab in KRAS Wild-type Metastatic Colorectal Cancer Patients

Yu-Hong Li, Fang Wang, Lin Shen, Yan-Ming Deng, Qiong Shao, Fen Feng, Xin An, Feng-Hua Wang, Zhi-Qiang Wang, Rui-Hua Xu, Jian-Yong Shao
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (2): 382–390.
https://doi.org/10.1158/1078-0432.CCR-10-0208
Published: 16 January 2011
View article titled, <em>EGFR</em> Fluorescence <em>In situ</em> Hybridization Pattern of Chromosome 7 Disomy Predicts Resistance to Cetuximab in KRAS Wild-type Metastatic Colorectal Cancer Patients
Open the PDF for <em>EGFR</em> Fluorescence <em>In situ</em> Hybridization Pattern of Chromosome 7 Disomy Predicts Resistance to Cetuximab in KRAS Wild-type Metastatic Colorectal Cancer Patients in another window
Includes: Supplementary data
Journal Articles

High Levels of Nucleolar Expression of Nucleolin Are Associated with Better Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma

Lan Peng, John Liang, Hua Wang, Xianzhou Song, Asif Rashid, Henry F. Gomez, Lynda J. Corley, James L. Abbruzzese, Jason B. Fleming, Douglas B. Evans, Huamin Wang
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (14): 3734–3742.
https://doi.org/10.1158/1078-0432.CCR-09-3411
Published: 14 July 2010
View article titled, High Levels of Nucleolar Expression of Nucleolin Are Associated with Better Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma
Open the PDF for High Levels of Nucleolar Expression of Nucleolin Are Associated with Better Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma in another window
Journal Articles

miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy

Liana Adam, Meng Zhong, Woonyoung Choi, Wei Qi, Milena Nicoloso, Ameeta Arora, George Calin, Hua Wang, Arlene Siefker-Radtke, David McConkey, Menashe Bar-Eli, Colin Dinney
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (16): 5060–5072.
https://doi.org/10.1158/1078-0432.CCR-08-2245
Published: 12 August 2009
View article titled, miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy
Open the PDF for miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy in another window
Includes: Supplementary data
Journal Articles

Variable Clinical Presentations of Nasal and Waldeyer Ring Natural Killer/T-Cell Lymphoma

Ye-Xiong Li, Qing-Feng Liu, Hui Fang, Shu-Nan Qi, Hua Wang, Wei-Hu Wang, Yong-Wen Song, Jiade Lu, Jing Jin, Shu-Lian Wang, Yue-Ping Liu, Ning Lu, Xin-Fan Liu, Zi-Hao Yu
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (8): 2905–2912.
https://doi.org/10.1158/1078-0432.CCR-08-2914
Published: 15 April 2009
View article titled, Variable Clinical Presentations of Nasal and Waldeyer Ring Natural Killer/T-Cell Lymphoma
Open the PDF for Variable Clinical Presentations of Nasal and Waldeyer Ring Natural Killer/T-Cell Lymphoma in another window
Includes: Supplementary data
Journal Articles

Expression of MAP4K4 Is Associated with Worse Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma

John J. Liang, Hua Wang, Asif Rashid, Tse-Hua Tan, Rosa F. Hwang, Stanley R. Hamilton, James L. Abbruzzese, Douglas B. Evans, Huamin Wang
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (21): 7043–7049.
https://doi.org/10.1158/1078-0432.CCR-08-0381
Published: 03 November 2008
View article titled, Expression of MAP4K4 Is Associated with Worse Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma
Open the PDF for Expression of MAP4K4 Is Associated with Worse Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma in another window
Journal Articles

Identification of α-Enolase as an Autoantigen in Lung Cancer: Its Overexpression Is Associated with Clinical Outcomes

Gee-Chen Chang, Ko-Jiunn Liu, Chia-Ling Hsieh, Tsai-Shu Hu, Suparat Charoenfuprasert, Hsiung-Kun Liu, Kwen-Tay Luh, Li-Han Hsu, Chew-Wen Wu, Chou-Chik Ting, Chih-Yi Chen, Kun-Chieh Chen, Tsung-Ying Yang, Teh-Ying Chou, Wen-Hua Wang, Jacqueline Whang-Peng, Neng-Yao Shih
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (19): 5746–5754.
https://doi.org/10.1158/1078-0432.CCR-06-0324
Published: 04 October 2006
View article titled, Identification of α-Enolase as an Autoantigen in Lung Cancer: Its Overexpression Is Associated with Clinical Outcomes
Open the PDF for Identification of α-Enolase as an Autoantigen in Lung Cancer: Its Overexpression Is Associated with Clinical Outcomes in another window
Includes: Supplementary data
Journal Articles

A Small Interfering RNA Targeting Vascular Endothelial Growth Factor Inhibits Ewing's Sarcoma Growth in a Xenograft Mouse Model

Hui Guan, Zhichao Zhou, Hua Wang, Shu-Fang Jia, Wenbiao Liu, Eugenie S. Kleinerman
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (7): 2662–2669.
https://doi.org/10.1158/1078-0432.CCR-04-1206
Published: 06 April 2005
View article titled, A Small Interfering RNA Targeting Vascular Endothelial Growth Factor Inhibits Ewing's Sarcoma Growth in a Xenograft Mouse Model
Open the PDF for A Small Interfering RNA Targeting Vascular Endothelial Growth Factor Inhibits Ewing's Sarcoma Growth in a Xenograft Mouse Model in another window
Journal Articles

Defective Expression of Transforming Growth Factor β Receptor Type II Is Associated with CpG Methylated Promoter in Primary Non-Small Cell Lung Cancer

Hong-Tao Zhang, Xiao-Feng Chen, Ming-Hua Wang, Jiu-Cun Wang, Qing-Yuan Qi, Rong-Mei Zhang, Wei-Qing Xu, Qing-Yan Fei, Fei Wang, Qi-Qun Cheng, Feng Chen, Cheng-Song Zhu, Shi-Heng Tao, Zewei Luo
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (7): 2359–2367.
https://doi.org/10.1158/1078-0432.CCR-0959-3
Published: 08 April 2004
View article titled, Defective Expression of Transforming Growth Factor β Receptor Type II Is Associated with CpG Methylated Promoter in Primary Non-Small Cell Lung Cancer
Open the PDF for Defective Expression of Transforming Growth Factor β Receptor Type II Is Associated with CpG Methylated Promoter in Primary Non-Small Cell Lung Cancer in another window